# GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes

> **NCT01414556** · EARLY_PHASE1 · COMPLETED · sponsor: **Mikkel Christensen** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Glucose-dependent Insulinotropic polypeptide
- **OTHER:** saline

## Key facts

- **NCT ID:** NCT01414556
- **Lead sponsor:** Mikkel Christensen
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414556, "GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01414556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*